Acta dermato-venereologica · 2014
Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Salmi Teea T, Hervonen Kaisa, Laurila Kaija, Collin Pekka, Mäki Markku, Koskinen Outi, Huhtala Heini, Kaukinen Katri, Reunala Timo
Аннотация
Dermatitis herpetiformis (DH) is an extraintestinal manifestation of coeliac disease. Untreated coeliac disease patients are known to have transglutaminase 2 (TG2)-targeted IgA deposits in the small bowel mucosa. To evaluate whether similar intestinal IgA deposits are also present in DH and whether the deposits disappear with gluten-free diet, 47 untreated and 27 treated DH patients were studied. Seventy-nine percent of untreated and 41% of the treated DH patients had TG2-specific IgA deposits in the small bowel, and the presence of the deposits showed a significant association with the degree of small bowel villous atrophy (p < 0.001). Other coeliac-disease related inflammatory markers were also investigated, and the density of small bowel mucosal intraepithelial γδ(+) T cells was increased in 91% of untreated and 73% of treated DH patients. The results show that the majority of untreated DH patients have similar gluten-dependent TG2-specific IgA deposits the small bowel mucosa as coeliac disease patients.
Предметные рубрики MeSH
AdolescentAdultAgedAtrophyAutoantibodiesAutoimmunityBiomarkersCeliac DiseaseDermatitis HerpetiformisDiet, Gluten-FreeFemaleGTP-Binding ProteinsHumansImmunoglobulin AIntestinal MucosaIntestine, SmallMaleMiddle AgedProtein Glutamine gamma Glutamyltransferase 2TransglutaminasesTreatment OutcomeYoung Adult